“Immunological and Virological Outcomes among Treatment Experienced HIV-Infected Patients on Dolutegravir Regimen in Tanzania”, TMJ, vol. 32, no. 4, pp. 28–39, Nov. 2021, doi: 10.4314/tmj.v32i4.512.